A Phase II, Study to Determine the Preliminary Efficacy of Novel Combinations of Treatment in Patients With Platinum Refractory Extensive-Stage Small-Cell Lung Cancer
Clinical trial NCT02937818 · COMPLETED
Trial details
- NCT number
- NCT02937818
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-28
- Primary completion
- 2020-06-22
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.